Screening for Vulnerability in the Elderly Supported at the Oscar Lambret Centre

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01415258

Acronym

VULNERABILITE

Enrollment

209

Registered

2011-08-11

Start date

2011-03-01

Completion date

2012-04-01

Last updated

2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solid Tumor

Keywords

cancer, vulnerability, frail

Brief summary

The objective of this study is to uncover the prevalence of vulnerability among patients aged ≥ 70 coming to the medical oncology division of the Oscar Lambret Centre, according to the short screening test Vulnerable Elders Survey 13 (VES-13). The objective is to better understand the value of routine screening of patients before the consultation, it was proposed as a secondary objective of this study to assess the correlation between the identification of the vulnerability in the screening test VES-13 and the identification made by the clinician during the consultation. The correlation between VES-13 and opinion of the clinician for three categories of patients (self - intermediate - fragile) will also be studied.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

70 Years to No maximum

Healthy volunteers

Inclusion criteria

* patient aged ≥ 70 * coming for a first visit, whatever the purpose and the disease stage

Exclusion criteria

* neglect or refusal to answer to the VES-13 test

Design outcomes

Primary

Measure	Time frame	Description
To assess the Vulnerable Elders Survey score (VES-13)	Within 3 months after recruitment	A patient is identified vulnerable if the score is ≥ 3

Secondary

Measure	Time frame	Description
To assess the correlation between the VES-13 score and the vulnerability judged by a clinical expert	Within 3 months after recruitment	A patient will be identified as vulnerable if he/she belongs to the "intermediate" or "frail" category. The Kappa coefficient of agreement will be used to correlate the VES-13 score and clinical observations.
To measure the muscle strength using the grip strength test	Within 3 months after recruitment	Hand Dynamometer Range values : 0-90

Countries

France

Contacts

PRINCIPAL_INVESTIGATORVéronique SERVENT, MD

Oscar Lambret Anti-Cancer Centre

Outcome results